Financhill
Sell
21

ARCT Quote, Financials, Valuation and Earnings

Last price:
$12.88
Seasonality move :
23.59%
Day range:
$11.60 - $12.93
52-week range:
$11.60 - $45.00
Dividend yield:
0%
P/E ratio:
8.50x
P/S ratio:
2.51x
P/B ratio:
1.45x
Volume:
559.3K
Avg. volume:
433.2K
1-year change:
-61.12%
Market cap:
$349.3M
Revenue:
$138.4M
EPS (TTM):
-$3.01

Earnings Data

Next earnings date for ARCT
May 08
2025
Most recent earnings per share
-$1.11
Missed by $0.62
(Mar 6/2025)
Consensus Estimate
-$0.49
(Mar 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $25.6M -- -- -$1.00 --
03/06/2025 Q4 $44.6M $21M -$1.11 -$0.49 -$0.62
11/07/2024 Q3 $36.6M $38.8M -$0.26 -$1.02 $0.76
08/05/2024 Q2 $22.2M $46M -$0.64 -$1.57 $0.93
05/08/2024 Q1 $17.7M $32.6M -$1.00 -$1.14 $0.14
03/07/2024 Q4 $37.9M $25.1M -$0.32 -$1.05 $0.73
11/14/2023 Q3 -- -- -$0.61 -$1.63 $1.02
08/07/2023 Q2 -- -- -$1.98 -$0.42 -$1.56
05/09/2023 Q1 -- -- $1.87 $0.65 $1.22
03/28/2023 Q4 -- -- $4.43 $1.23 $3.20
11/09/2022 Q3 -- -- -$1.33 -$1.81 $0.48
08/09/2022 Q2 -- -- -$0.82 -$1.88 $1.06
05/09/2022 Q1 -- -- -$1.94 -$1.40 -$0.54
02/28/2022 Q4 -- -- -$1.47 -$1.69 $0.22
11/08/2021 Q3 -- -- -$2.05 -$1.52 -$0.53
08/10/2021 Q2 -- -- -$2.07 -$2.25 $0.18
05/10/2021 Q1 -- -- -$2.15 -$1.23 -$0.92
03/01/2021 Q4 -- -- -$1.36 -$0.86 -$0.50
11/09/2020 Q3 -- -- -$0.92 -$0.49 -$0.43
08/10/2020 Q2 -- -- -$0.55 -- --
05/07/2020 Q1 -- -- -$0.67 -$0.72 $0.05
03/11/2020 Q4 -- -- -$0.76 -$0.63 -$0.13
11/07/2019 Q3 -- -- -$0.56 -$0.65 $0.09
08/15/2019 Q2 -- -- -- -$0.67 --
05/13/2019 Q1 -- -- -- -$0.60 --
03/18/2019 Q4 -- -- -- -$0.52 --
10/01/2018 Q3 -- -- -- -$0.35 --
06/30/2018 Q2 -- -- -- -$0.34 --
05/14/2018 Q1 -- -- -- -$0.33 --
12/31/2017 Q4 -- -- -- -- --
11/09/2017 Q3 -- -- -- -- --
08/11/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
02/15/2017 Q4 -- -- -- -- --
11/15/2016 Q3 -- -- -- -- --
08/30/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --

Arcturus Therapeutics Holdings Earnings Questions

  • How Much did Arcturus Therapeutics Holdings Generate in Revenue Last Quarter?

    Arcturus Therapeutics Holdings reported $21M worth of top line sales in its most recent quarter.

  • Did Arcturus Therapeutics Holdings Beat Earnings Last Quarter?

    Arcturus Therapeutics Holdings announced earnings per share of -$1.11 which represents a miss of analyst forecast a -$0.49 per share.

  • Is Arcturus Therapeutics Holdings Profitable?

    Arcturus Therapeutics Holdings reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Arcturus Therapeutics Holdings EPS Next Year?

    Arcturus Therapeutics Holdings's earnings are forecast to decrease from -$3.00 per share to -$2.38 per share next year representing a decrease of -47.04%.

  • When is Arcturus Therapeutics Holdings's Earnings Date?

    Arcturus Therapeutics Holdings's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock